Morphine antibody (FITC)

Catalog No. ABIN723283

Product Details anti-Morphine Antibody (FITC)

Target: Morphine

Reactivity: Please inquire

Host: Mouse

Clonality: Monoclonal

Conjugate: This Morphine antibody is conjugated to FITC

Application: Immunofluorescence (Paraffin-embedded Sections) (IF (p))

Purification: Purified by Protein G.

Immunogen: KLH conjugated Morphine molecular modified

Clone: 2F11

Isotype: IgG

Application Details

Application Notes: IF(IHC-P)(1:50-200)

Comment:

Exitation/Emission: 494nm/518nm

Restrictions: For Research Use only

Handling

Format: Liquid

Concentration: 1 μg/μL

Buffer: Aqueous buffered solution containing 100 μg/mL BSA, 50 % glycerol and 0.09 % sodium azide.

Preservative: Sodium azide

Precaution of Use: This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

Storage: -20 °C

Storage Comment: Store at 4°C

Expiry Date: 12 months

Target Details for Morphine

Target: Morphine

Abstract: Morphine Products

Target Type: Chemical

Background:

Morphine is thought to produce reinforcement phenomena via stimulation of mu, delta, and kappa opioid receptors that regulate stress perception, pain control, reward behavior, and neurohormone secretion in reward-relevant brain systems. It has the highest affinity for mu, followed by delta and kappa. Rapid activation of the mu opioid receptor by morphine results in a euphoric phenotype, thus conferring the reinforcing effects of the drug. This activation is accompanied by extracellular dopamine release, which alters several events related to the cAMP signal transduction pathway. Of particular significance is that CREB seems to be modified by morphine, thereby affecting addictive behavioral phenomena, such as withdrawal symptoms.

Synonyms: Morphine 6.